Friday, December 5, 2025
Search

Canadian Solar And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

November 15, 2022

Canadian Solar  And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Canadian Solar (CSIQ), Neurocrine Biosciences (NBIX), Ryanair Holdings (RYAAY) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Canadian Solar (CSIQ)

38% sales growth and 8.6% return on equity

Canadian Solar Inc. and its affiliates design, develop, manufacture, and market solar cells, modules and wafers. It operates in two divisions: Module and System Solutions, (MSS), and Energy. MSS is a segment that designs, develops, manufactures, and sells a variety of solar power products. These include standard and specialty modules as well as solar systems kits. Ready-to-install solar packages consisting of inverters and racking systems. The company also offers engineering, procurement and construction services, as well as operation and maintenance (O&M). The energy solutions offered by this segment include energy storage and solar inverters for residential and commercial use. O&M includes inspections, repairs, and replacements of equipment, as well as site management, administrative support, and assistance with solar power project projects. This segment is involved in developing and selling solar power projects, as well as operating solar power plants. This segment was home to a total of 880.2 MWp solar power plants as of January 31, 2020. Distributors, system integrators and project developers are the company's main customers. Canadian Solar Inc. is a distributor of its products under the Canadian Solar brand. It also sells on an OEM basis. The company has offices in North America and South America. It also operates internationally. Guelph is the headquarters of this company, which was established in 2001.

Earnings per Share

Canadian Solar's trailing 12 month EPS is $2.05.

PE Ratio

Canadian Solar's trailing 12-month price-earnings ratio is 16.9. The purchaser of the shares is therefore investing $16.9 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 8.6%.

Sales Growth

Canadian Solar has seen a 68.7% increase in sales for its current quarter, and an additional 38% the following.

2. Neurocrine Biosciences (NBIX)

31.2% sales growth and 4.03% return on equity

Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.

Earnings Per Share

As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $0.59.

PE Ratio

Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 208.85. Meaning, the purchaser of the share is investing $208.85 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.03%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31%, now sitting on 1.39B for the twelve trailing months.

3. Ryanair Holdings (RYAAY)

23.9% sales growth and 4.11% return on equity

Ryanair Holdings plc and its subsidiaries provide scheduled passenger airline services throughout Europe, including the United Kingdom of Ireland, Spain, Italy, Spain and Germany. The company also provides ancillary services such as in-flight sales of drinks, food, duty free, merchandise, and car rental and accommodation services. It even offers travel insurance via its mobile app and website. The company also offers passenger and aircraft handling, ticketing and maintenance and repairs services. It markets car parking and fast-track airport transfers as well as attractions and activities through its mobile app and website. It had a fleet of 483 Boeing 737 planes and 29 Airbus A320 airplanes as its principal aircraft. The company also offered around 3,000 short-haul flights daily to approximately 225 airports. Ryanair Holdings plc, which was established in 1985 is headquartered at Swords in Ireland.

Earnings Per Share

As for profitability, Ryanair Holdings has a trailing twelve months EPS of $-7.24.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.11%.

Annual Top and Bottom Value

Ryanair Holdings stock was valued at $77.36 as of 19:22 EST. This is way lower than the 52-week high $125.75, and much higher than its 52 week low of $55.90.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter is 202.2% and a drop 166.7% for the next.

Sales Growth

Ryanair Holdings has a 35.6% and 23.9% sales growth for the current quarter.

Moving Average

Ryanair Holdings is worth more than its 50-day average moving price of $65.97, and less than its 200-day average moving price of $80.01.

4. MVB Financial Corp. (MVBF)

21.2% sales growth and 10.73% return on equity

MVB Financial Corp., together with its subsidiaries, provides banking and mortgage products and services to individuals and corporate clients in the United States. The company operates through three segments: Commercial and Retail Banking; Mortgage Banking; and Financial Holding Company. It offers various demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and grants various types of loans, including commercial and commercial real estate loans, residential real estate loans, home equity lines of credit, and consumer loans. The company also provides debit cards; cashier's checks; safe deposit rental facilities; and non-deposit investment services, as well as automated teller machines, and internet and telephone banking services. The company operates 13 full-service banking branches; ten offices in West Virginia; and three in Virginia. MVB Financial Corp. was founded in 1997 and is headquartered in Fairmont, West Virginia.

Earnings Per Share

As for profitability, MVB Financial Corp. has a trailing twelve months EPS of $2.16.

PE Ratio

MVB Financial Corp. has a trailing twelve months price to earnings ratio of 11.73. Meaning, the purchaser of the share is investing $11.73 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.73%.

Sales Growth

MVB Financial Corp.'s sales growth is 12.8% for the present quarter and 21.2% for the next.

5. Eagle Bulk Shipping (EGLE)

17.6% sales growth and 38.84% return on equity

Eagle Bulk Shipping Inc. is involved in ocean shipping dry bulk cargoes around the world. It charters and manages dry bulk vessels to transport various bulk cargoes such as iron ore, coke, grain, fertilizers and steel products. The company serves producers, traders and end-users. The company had 53 vessels in its fleet as of December 31, 2021. Eagle Bulk Shipping Inc. is located in Stamford Connecticut.

Earnings per Share

Eagle Bulk Shipping's trailing 12 month EPS is $-3.4.

For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 38.84%.

6. SciPlay Corporation (SCPL)

14.2% sales growth and 21.25% return on equity

SciPlay Corporation markets and develops social games on mobile platforms and websites across North America. You can play social casino games like Jackpot Party Casino and Gold Fish Casino. Social casino games offered by the company include both slots-style and table-style play. Casual games combine slots-style, bingo or adventure play with game elements. The company also provides content and titles from licensed third parties. The original name of the company was SG Social Games Corporation. In March 2019, SciPlay Corporation took over that title. SciPlay Corporation was established in 1997. It is located in Las Vegas. SciPlay Corporation, Scientific Games Corporation's subsidiary.

Earnings Per Share

As for profitability, SciPlay Corporation has a trailing twelve months EPS of $0.73.

PE Ratio

SciPlay Corporation has a trailing twelve months price to earnings ratio of 19.18. Meaning, the purchaser of the share is investing $19.18 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.25%.

Moving Average

SciPlay Corporation's worth is way above its 50-day moving average of $12.09 and higher than its 200-day moving average of $12.84.

Volume

Today's last reported volume for SciPlay Corporation is 87948 which is 61.33% below its average volume of 227446.

Annual Top and Bottom Value

SciPlay Corporation stock was valued at $14.00 as of 19:23 EST. This is way lower than the 52-week high at $21.88 but much higher than its low 52-week of $10.60.

7. ChannelAdvisor Corporation (ECOM)

7.7% sales growth and 25.85% return on equity

ChannelAdvisor Corporation provides software-as-a-service (SaaS) solutions in the United States and internationally. SaaS is a cloud platform which helps retailers and brands to increase their online sales by connecting with customers around the globe, expanding their sales channels and optimizing their operations to maximize their competitiveness. The company's solutions range from Marketplaces module to connect customers with third-party marketplaces to Digital Marketing module which allows customers to search for shopping websites that will allow them to list products online. It also provides a Where to Buy service that allows companies to give information to their Web visitors and digital marketing audience about authorized resellers who carry their products. Product Intelligence is a solution that gives brands insights into online product assortment, price trends and coverage gaps. Customers include brands, retailers and advertising agencies who use the company's solutions for their clients. It was established in 2001 in Morrisville in North Carolina.

Earnings per Share

ChannelAdvisor Corporation's trailing 12 months EPS is $1.3.

PE Ratio

ChannelAdvisor Corporation's trailing 12-month price-earnings ratio is 17.72. The purchaser of the shares is therefore investing $17.72 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 25.85%.

8. Shutterstock (SSTK)

6.3% sales growth and 17.65% return on equity

Shutterstock, Inc., is a technology company that provides content, tools, and services throughout North America, Europe, as well as internationally. Image services include vectors and images, as well as footage services. These are services that can be used for visual communication, such websites, print and digital marketing materials and publications. They also offer video services. This includes video clips filmed by experts in the industry and high-definition and 4K video formats. The videos are then integrated into social media and marketing campaigns. It offers its services under Shutterstock Select and Shutterstock Custom brand names. The company serves small- and medium-sized business owners, broadcast and media companies as well as marketing professionals. Shutterstock, Inc. and Wochit, Inc. have a strategic alliance to share technology in enterprise video creation. It was established in 2003. The headquarters are located in New York, New York.

Earnings Per Share

As for profitability, Shutterstock has a trailing twelve months EPS of $2.64.

PE Ratio

Shutterstock has a trailing twelve months price to earnings ratio of 17.42. Meaning, the purchaser of the share is investing $17.42 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.65%.

Sales Growth

Shutterstock saw a 9.4% increase in sales for the current quarter, and 6.3% the following.